These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31730577)

  • 21. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
    [No Abstract]   [Full Text] [Related]  

  • 22. Highlights in B-cell malignancies from the 61st American Society of Hematology Annual Meeting: commentary.
    Furman RR
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 8(2):24-26. PubMed ID: 33843883
    [No Abstract]   [Full Text] [Related]  

  • 23. Highlights in CAR T-cell therapy from the 61st American Society of Hematology Annual Meeting: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 7(2):20-23. PubMed ID: 33843872
    [No Abstract]   [Full Text] [Related]  

  • 24. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918
    [No Abstract]   [Full Text] [Related]  

  • 25. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
    Awan FT
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
    [No Abstract]   [Full Text] [Related]  

  • 26. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    DiPersio JF
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914
    [No Abstract]   [Full Text] [Related]  

  • 27. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Davids MS
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
    [No Abstract]   [Full Text] [Related]  

  • 28. Highlights in cutaneous T-cell lymphoma from the 60th American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 3(2):1-24. PubMed ID: 31545304
    [No Abstract]   [Full Text] [Related]  

  • 29. Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 14(9):20-23. PubMed ID: 33843881
    [No Abstract]   [Full Text] [Related]  

  • 30. The 51st annual meeting of the American Society of Hematology.
    Muneer S; Ranganathan A; Schlager S;
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):90-7. PubMed ID: 20371441
    [No Abstract]   [Full Text] [Related]  

  • 31. Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Bartlett NL
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 6(2):18-23. PubMed ID: 25856285
    [No Abstract]   [Full Text] [Related]  

  • 32. Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Horwitz SM
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 5(2):19-22. PubMed ID: 25856174
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mantle cell lymphoma in the era of targeted-therapy-in-depth report on American Society of Hematology 53rd annual meeting].
    Liang R; Shi YK; Han XH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):690-2. PubMed ID: 23134877
    [No Abstract]   [Full Text] [Related]  

  • 34. 49th Annual Meeting of the American Society of Hematology, Atlanta, GA; December 8-11, 2007.
    Clin Lymphoma Myeloma; 2008 Apr; 8(2):77-86. PubMed ID: 18564453
    [No Abstract]   [Full Text] [Related]  

  • 35. Summer happenings in Hematology 2011. Highlights in Hematological Malignancies form the 2011 American Society Clinical Oncology Annual Meeting and the 16th Congress of the European Hematology Association, and the 11th International Conference on Malignancy Lymphoma.
    Ashforth E; Cheson BD
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 17):1-24. PubMed ID: 22361949
    [No Abstract]   [Full Text] [Related]  

  • 36. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Winter A
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):14-18. PubMed ID: 35343942
    [No Abstract]   [Full Text] [Related]  

  • 37. Highlights in mantle cell lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Flinn I
    Clin Adv Hematol Oncol; 2021 Apr; 19 Suppl 13(4):17-19. PubMed ID: 35290296
    [No Abstract]   [Full Text] [Related]  

  • 38. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Goy AH
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):18-23. PubMed ID: 35343947
    [No Abstract]   [Full Text] [Related]  

  • 39. [Report on new target drug of lymphoma in the 55th annual meeting of American Society of Hematology].
    Shu M; Gu H; Gao G; Dong B; Chen X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):376-8. PubMed ID: 24759036
    [No Abstract]   [Full Text] [Related]  

  • 40. Meeting highlights 46th annual meeting of the American Society of Hematology December 2004 San Diego, California.
    Price N; Reddy GK; Jain VK
    Clin Lymphoma; 2004 Dec; 5(3):144-8. PubMed ID: 15636687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.